Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic MelanomaDouglas B. Johnson, Naveen Dakappagari, Ju Young Kim et al.|Clinical Cancer Research|2018Cited by 176